Back to search

Article

New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study

2024-04-25

Abstract excerpt

<title>Abstract</title> <p>Primary sclerosing cholangitis (PSC) lacks specific drugs. Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), have shown potential for improving PSC prognosis, but their therapeutic efficacy remains controversial. We analyzed HMGCR single nucleotide polymorphisms (SNPs) from published genome-wide association studies using Mendelian randomization (MR) to asse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b2bfa33-e41b-52db-9ddd-da46ed5b660a
DOI
10.21203/rs.3.rs-4262308/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization studyDOI 10.21203/rs.3.rs-4262308/v1
Select a neighboring publication to make it the new centre.